BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IGCS - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IGCS
X-ORIGINAL-URL:https://igcs.org
X-WR-CALDESC:Events for IGCS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221207T103000
DTEND;TZID=America/New_York:20221207T113000
DTSTAMP:20260414T235839
CREATED:20221130T160350Z
LAST-MODIFIED:20221206T211339Z
UID:63211-1670409000-1670412600@igcs.org
SUMMARY:Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions
DESCRIPTION:Join us for an overview of the InnovaTV 204 trial data along with InnovaTV 205 data\, as well as ongoing trials including InnovaTV 301. \nWednesday\, December 7\, 2022\n10:30 AM ET | See all time zones\nDuration approximately 30 minutes\nSupported in part by Seagen \nRegister Here \n\nRobert Coleman\, MD\nChief Scientific Officer\,\nUS Oncology Research\nUSA
URL:https://igcs.org/event/second-line-treatment-options-for-patients-with-recurrent-cervical-cancer-review-of-current-treatment-and-future-directions/
LOCATION:Zoom Video Conference\, United States
CATEGORIES:Global Events,IGCS Hosted Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221215T143000
DTEND;TZID=America/New_York:20221215T150000
DTSTAMP:20260414T235839
CREATED:20221206T210513Z
LAST-MODIFIED:20221206T211438Z
UID:63307-1671114600-1671116400@igcs.org
SUMMARY:Overall Survival Data with PARP Inhibitor: Myth vs. Reality
DESCRIPTION:Advances & Updates Webinar:\nOverall Survival Data with PARP Inhibitor: Myth vs. Reality \nThursday\, December 15\, 2022\n2:30 PM ET | See all time zones\nDuration approximately 30 minutes \n  \nRegister Here  \n  \n \nMansoor Mirza\, MD\nChief Oncologist\, Rigshospitalet\nMedical Director\, NSGO-CTU\nDenmark \n  \n \nSupported in part by GSK
URL:https://igcs.org/event/overall-survival-data-with-parp-inhibitor-myth-vs-reality/
LOCATION:Zoom Video Conference\, United States
CATEGORIES:Global Events,IGCS Hosted Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221220T110000
DTEND;TZID=America/New_York:20221220T120000
DTSTAMP:20260414T235839
CREATED:20221206T211145Z
LAST-MODIFIED:20221206T211228Z
UID:63309-1671534000-1671537600@igcs.org
SUMMARY:Radiation Oncology ECHO
DESCRIPTION:Radiation Oncology ECHO \nRadiation Oncologist experts provide advice for patient case presented by Dr. Vinita Thampy of India. ECHO will include case presentation\, distillation\, panel discussion\, and Q&A. \nTuesday\, December 20\, 2022\n11:00 AM ET | See all time zones\nDuration approximately 60 minutes \nRegister Here  \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nVinita Thampy\, MD\nCase presenter\nIndia \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThomas Ram\, MD\nDistillation\nIndia \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRemi Nout\, MD\nModerator\nNetherlands \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSusan Mathews\, MD\nFeatured panelist\nIndia \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nHannah Simonds\, MD\nFeatured panelist\nUnited Kingdom \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAnuja Jhingran\, MD\nFeatured panelist\nUnited States \n\n\n\n\n\n\n\n\n 
URL:https://igcs.org/event/radiation-oncology-echo/
LOCATION:Zoom Video Conference\, United States
CATEGORIES:Global Events,IGCS Hosted Events
END:VEVENT
END:VCALENDAR